Maryland Health Occupations Section 12-6A-06

CAUTION: READ FULL TEXT OF SECTION FOR SPECIAL NOTE

// SPECIAL NOTE: THE FOLLOWING SECTION WAS ADDED BY CHAPTER 249 OF 2002 AND WILL REMAIN IN EFFECT UNTIL MAY 31, 2008 //

      (a)      A protocol under this subtitle:

            (1)      May authorize:

                  (i)      The modification, continuation, and discontinuation of drug therapy under written, disease-state specific protocols;

                  (ii)      The ordering of laboratory tests; and

                  (iii)      Other patient care management measures related to monitoring or improving the outcomes of drug or device therapy; and

            (2)      May not authorize acts that exceed the scope of practice of the parties to the therapy management contract.

      (b)      A protocol shall prohibit the substitution of a chemically dissimilar drug product by the pharmacist for the product prescribed by the physician, unless permitted in the therapy management contract.